AbstractTriggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola disease, an early-onset recessive form of dementia preceded by bone cysts and fractures. The same type of mutations has recently been shown to cause frontotemporal dementia (FTD) without the presence of any bone phenotype. Here, we further confirm the association of TREM2 mutations with FTD-like phenotypes by reporting the first compound heterozygous mutation in a Turkish family
Rare coding variants in the triggering receptor expressed on myeloid cells‐2 (TREM2) gene have been ...
The triggering receptor expressed on myeloid 2 (TREM2) is an immune phagocytic receptor expressed on...
Nasu-Hakola disease is a rare, recessively inherited disease characterized by presenile dementia and...
Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola dise...
A causative association was recently demonstrated between homozygous TREM2 mutations and frontotempo...
TREM2 mutations were first identified in Nasu-Hakola disease, a rare autosomal recessive disease cha...
Homozygous mutations in exon 2 of TREM2, a gene involved in Nasu-Hakola disease, can cause frontotem...
Frontotemporal dementia (FTD) is a clinically and genetically heterogeneous disorder. Rare TREM2 var...
Frontotemporal dementia (FTD) is clinically characterized by behavioral changes, language impairment...
Homozygous mutations in TREM2 have been recently identified by exome sequencing in families presenti...
Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increa...
The differential diagnosis of young-onset progressive dementia is an issue that requires effort. Rec...
Triggering Receptor Expressed on Myeloid cells (TREM)2 deficiency originates a genetic syndrome char...
Summary Alzheimer's disease is a genetically complex disorder; rare variants in the triggering rece...
BACKGROUND: Homozygous loss-of-function mutations in TREM2, encoding the triggering receptor express...
Rare coding variants in the triggering receptor expressed on myeloid cells‐2 (TREM2) gene have been ...
The triggering receptor expressed on myeloid 2 (TREM2) is an immune phagocytic receptor expressed on...
Nasu-Hakola disease is a rare, recessively inherited disease characterized by presenile dementia and...
Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola dise...
A causative association was recently demonstrated between homozygous TREM2 mutations and frontotempo...
TREM2 mutations were first identified in Nasu-Hakola disease, a rare autosomal recessive disease cha...
Homozygous mutations in exon 2 of TREM2, a gene involved in Nasu-Hakola disease, can cause frontotem...
Frontotemporal dementia (FTD) is a clinically and genetically heterogeneous disorder. Rare TREM2 var...
Frontotemporal dementia (FTD) is clinically characterized by behavioral changes, language impairment...
Homozygous mutations in TREM2 have been recently identified by exome sequencing in families presenti...
Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increa...
The differential diagnosis of young-onset progressive dementia is an issue that requires effort. Rec...
Triggering Receptor Expressed on Myeloid cells (TREM)2 deficiency originates a genetic syndrome char...
Summary Alzheimer's disease is a genetically complex disorder; rare variants in the triggering rece...
BACKGROUND: Homozygous loss-of-function mutations in TREM2, encoding the triggering receptor express...
Rare coding variants in the triggering receptor expressed on myeloid cells‐2 (TREM2) gene have been ...
The triggering receptor expressed on myeloid 2 (TREM2) is an immune phagocytic receptor expressed on...
Nasu-Hakola disease is a rare, recessively inherited disease characterized by presenile dementia and...